Community Webinar: FDA Approved Agamree and Catalyst Pathways

April 25, 2024 1:00PM

Join Jett Foundation’s Community Webinar Series on April 25 at 1pm ET to hear an overview from the team at Catalyst Pharmaceuticals on their FDA approved Agamree & Catalyst Pathways. Registration is free and we hope you will tune in.

Catalyst Pharmaceuticals: FDA Approved Agamree & Catalyst Pathways
Thursday, April 25, 2024
1pm ET | 12pm CT | 11am MT | 10am PT


Carrie Ostrea - Sr. Manager of Patient Advocacy

Carrie Ostrea, Sr. Manager of Patient Advocacy

Alison Anderson, MS, CGC – Medical Affairs Director, Neuromuscular

Alison Anderson, MS, CGC, Medical Affairs Director, Neuromuscular

Maria Pandolfo – Sr. Vice President, Patient Services & Market Access

Maria Pandolfo, Sr. Vice President, Patient Services & Market Access

Community Webinar Series - Better preparing for challenges in Duchenne

Our Community Webinar Series is focused on ensuring that our Duchenne community is better prepared for those unexpected moments, challenging medical decisions, and difficult stages when on a Duchenne journey.

No one ever expects Duchenne and there is no correct way to tackle a diagnosis, but we can always better prepare. This webinar series is an opportunity to equip yourself with more knowledge, resources, and tools for those real-life, often unanticipated, scenarios.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open